Marker Therapeutics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $1,103 | $1,232 | $861 | $349 |
Gross Profit | 1,232 | -3,315 | -2,786 | |
EBITDA | -1,883 | -1,998 | -4,261 | -4,446 |
EBIT | -1,998 | -4,261 | -8,602 | |
Net Income | -1,703 | -1,998 | -4,015 | -4,446 |
Net Change In Cash | 1,103 | 1,232 | 861 | 349 |
Free Cash Flow | -12,014,070,886 | -2,735 | -1,878 | -5,499 |
Cash | 16,068,048,000 | 17,589 | 10,461 | 13,693 |
Basic Shares | 15,310 | 16,757 | 13,956 | 11,106 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $3,546 | $6,591 | $3,311 | $3,513 |
Gross Profit | -6,876 | -7,105 | -8,454 | |
EBITDA | -12,437 | -11,118 | -11,792 | -17,001 |
EBIT | -11,118 | -14,581 | -19,791 | |
Net Income | -12,163 | -10,731 | -8,236 | -29,930 |
Net Change In Cash | 3,546 | 6,591 | 3,311 | 3,513 |
Free Cash Flow | -12,014,081,000 | -10,910 | -16,439 | -26,972 |
Cash | 16,068,048,000 | 19,192 | 15,111 | 11,782 |
Basic Shares | 15,310 | 8,980 | 8,809 | 8,351 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$0.04 |
2025-09-30 | -$0.12 |
2025-06-30 | -$0.29 |
2025-03-31 | -$0.42 |
